Stock Events

Stock Events

Jazz Pharmaceuticals 

$249.00
182
-$0.29-0.12% 11:40 Today

Statistics

Day High
249.88
Day Low
249.24
52W High
266.38
52W Low
123.87
Volume
71,452
Avg. Volume
-
Mkt Cap
16.18B
P/E Ratio
2,031.83
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-8.25
-2.79
2.67
8.13
Expected EPS
6.46797
Actual EPS
N/A

Financials

-8.35%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.27BRevenue
-356.15MNet Income

Analyst Ratings

285.31Average Price Target
The highest estimate is 322.00.
From 16 ratings within the last 6 months. This is not an investment recommendation.
Buy
94%
Hold
6%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JAZZ. It's not an investment recommendation.
Microsoft
33
MSFT
NVIDIA
31
NVDA
Apple
30
AAPL
Amazon
29
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap43.51B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing directly with Jazz Pharmaceuticals in the market for generic and specialty neurological and sleep disorder treatments.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie competes in various therapeutic areas including neuroscience, where it offers products that could directly compete with Jazz Pharmaceuticals' portfolio.
Lilly(Eli) &
LLY
Mkt Cap1.12T
Eli Lilly and Company has a strong presence in the psychiatric and neurological drug markets, making it a direct competitor to Jazz Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb operates in the biopharmaceutical sector focusing on innovative medicines that directly compete with Jazz Pharmaceuticals in areas such as cancer and immunological disorders.
Pfizer
PFE
Mkt Cap159.99B
Pfizer is a global pharmaceutical company with a broad portfolio that includes treatments for neurological conditions, directly competing with Jazz Pharmaceuticals.
Merck
MRK
Mkt Cap376.37B
Merck & Co., Inc. offers a range of pharmaceutical products that compete with Jazz Pharmaceuticals, especially in the areas of cancer and infectious diseases.
Novartis
NVS
Mkt Cap301.95B
Novartis AG competes with Jazz Pharmaceuticals in several areas, including neuroscience and oncology, with a strong emphasis on research and development.
Gilead Sciences
GILD
Mkt Cap181.18B
Gilead Sciences, Inc. is a biopharmaceutical company that competes with Jazz Pharmaceuticals in the development and marketing of drugs for serious diseases including HIV, liver diseases, and cancer.
Biogen
BIIB
Mkt Cap32.03B
Biogen Inc. focuses on neurological diseases and has a portfolio of treatments that compete with Jazz Pharmaceuticals in the neuroscience and neurology sector.
AMGEN
AMGN
Mkt Cap237.52B
Amgen Inc. is a biotechnology company with products that compete in various therapeutic areas, including oncology and neuroscience, making it a competitor to Jazz Pharmaceuticals.

About

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Show more...
CEO
Renee D. Gala
Employees
2890
Country
Ireland
ISIN
IE00B4Q5ZN47
WKN
000A1JS1K

Listings

MI
IT
1JAZZ.MI
XETRA
DE
J7Z.XETRA
MX
MX
JAZZN.MX
F
DE
J7Z.F

0 Comments

Share your thoughts

FAQ

What is Jazz Pharmaceuticals stock price today?▼
The current price of JAZZ is $249.00 USD — it has decreased by -0.12% in the past 24 hours. Watch Jazz Pharmaceuticals stock price performance more closely on the chart.
What is Jazz Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Jazz Pharmaceuticals stocks are traded under the ticker JAZZ.
Is Jazz Pharmaceuticals stock price growing?▼
JAZZ stock has risen by +0.24% compared to the previous week, the month change is a -2.4% fall, over the last year Jazz Pharmaceuticals has showed a +100.35% increase.
What is Jazz Pharmaceuticals market cap?▼
Today Jazz Pharmaceuticals has the market capitalization of 16.18B
When is the next Jazz Pharmaceuticals earnings date?▼
Jazz Pharmaceuticals is going to release the next earnings report on November 11, 2026.
What were Jazz Pharmaceuticals earnings last quarter?▼
JAZZ earnings for the last quarter are 5.71 USD per share, whereas the estimation was 6.18 USD resulting in a -7.53% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Jazz Pharmaceuticals revenue for the last year?▼
Jazz Pharmaceuticals revenue for the last year amounts to 4.27B USD.
What is Jazz Pharmaceuticals net income for the last year?▼
JAZZ net income for the last year is -356.15M USD.
How many employees does Jazz Pharmaceuticals have?▼
As of August 27, 2026, the company has 2,890 employees.
In which sector is Jazz Pharmaceuticals located?▼
Jazz Pharmaceuticals operates in the Health & Wellness sector.
When did Jazz Pharmaceuticals complete a stock split?▼
Jazz Pharmaceuticals has not had any recent stock splits.
Where is Jazz Pharmaceuticals headquartered?▼
Jazz Pharmaceuticals is headquartered in DUBLIN, Ireland.